Absci Quarterly Balance Sheet
NASDAQ: ABSIHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Absci financial position
As of Jun 30, 2026, Absci reported total assets of $268.9 million, up 28.1% from a year earlier against total liabilities of $22.8 million. Shareholders' equity stood at $246.1 million, or 91.5% of assets. The company held $107.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 10.63, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Absci balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 107.86M | 8.63M | 20.02M | 9.48M | 38.02M | 46.99M | 41.21M | 38.20M | 42.94M | 58.83M | 72.36M | 69.73M |
| Short-Term Investments | 93.28M | 117.08M | 124.27M | 143.00M | — | — | 71.21M | — | — | — | — | — |
| Receivables | — | — | — | 1.00M | 700.00K | 1.38M | 0 | — | — | — | 2.19M | — |
| Total Current Assets | 208.27M | 131.97M | 149.57M | 174.99M | 137.40M | 155.98M | 133.83M | 150.14M | 165.19M | 181.80M | 120.58M | 134.71M |
| Property, Plant & Equipment | 16.72M | 18.78M | 20.86M | 23.02M | 24.06M | 27.03M | 29.17M | 32.37M | 36.55M | 38.76M | 41.33M | 45.21M |
| Goodwill | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Intangible Assets | 40.05M | 40.77M | 41.51M | 42.36M | 43.20M | 44.04M | 44.88M | 45.73M | 46.57M | 47.41M | 48.25M | 49.09M |
| Long-Term Investments | 0 | 4.80M | 11.80M | 32.60M | — | — | — | — | — | — | — | — |
| Total Assets | 268.92M | 195.59M | 216.30M | 244.99M | 209.89M | 232.45M | 213.61M | 235.23M | 255.53M | 274.90M | 217.30M | 236.34M |
| Accounts Payable | 7.16M | 8.82M | 2.76M | 4.59M | 8.21M | 4.95M | 2.95M | 1.67M | 1.69M | 1.65M | 1.50M | 1.91M |
| Total Current Liabilities | 19.60M | 20.03M | 22.77M | 29.71M | 31.32M | 27.28M | 28.66M | 26.69M | 25.47M | 25.29M | 29.56M | 27.97M |
| Long-Term Debt | — | — | 0 | 65.00K | 161.00K | 682.00K | 1.26M | 2.15M | 3.12M | 3.75M | 4.66M | 5.55M |
| Total Liabilities | 22.79M | 23.62M | 26.85M | 34.65M | 36.52M | 33.65M | 34.48M | 33.90M | 34.04M | 34.79M | 41.12M | 39.93M |
| Shareholders' Equity | 246.13M | 171.97M | 189.45M | 210.34M | 173.37M | 198.80M | 179.13M | 201.34M | 221.49M | 240.11M | 176.18M | 196.42M |
| Retained Earnings | -687.59M | -654.38M | -624.78M | -595.22M | -566.52M | -535.95M | -509.60M | -480.62M | -453.22M | -428.47M | -406.50M | -382.95M |
| Total Debt | — | — | 0 | 65.00K | 161.00K | 682.00K | 1.26M | 2.15M | 3.12M | 3.75M | 4.66M | 5.55M |
| Net Cash (Debt) | 201.14M | 125.70M | 144.29M | 152.41M | 37.86M | 46.31M | 111.17M | 36.04M | 39.81M | 55.09M | 67.70M | 64.18M |
| Shares Outstanding | — | — | — | — | — | — | 115.36M | 114.19M | 113.44M | 113.00M | 93.09M | 92.94M |
This table shows 12 quarterly periods of Absci's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ABSI's reporting calendar. What is a balance sheet?